NCT04306302View on ClinicalTrials.gov

A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

December 24, 2020

Study Completion Date

December 24, 2020

Conditions
Healthy
Interventions
BIOLOGICAL

ExPEC10V

Participants will receive a single IM injection of ExPEC10V.

BIOLOGICAL

Placebo

Participants will receive single IM injection of matching placebo.

Trial Locations (1)

8120025

SOUSEIKAI PS Clinic, Fukuoka

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY

NCT04306302 - A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults | Biotech Hunter | Biotech Hunter